The study will include around 200 participants aged 65 or older with BMI of at least 35 starting semaglutide therapy.

Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

Empowering Membrane Process Engineers: TRUSTECH Launches the Online Assistant “MEMTOOLS” In capacity planning a ...

The Judicial Service Commission’s ( JSC’s) call for application for High Court judges has stirred legal debate with experts ...

Enterprise AI platform expands across diverse industry use cases Institutional participation shows active positioning shifts ...

The update comes as the therapy’s regulatory application awaits a decision from the U.S. Food and Drug Administration later ...

Southeast Asian digital platform group faces sharp market momentum shift recently E commerce gaming payments ecosystem shapes ...

Gubra today announces that a clinical trial application (CTA) for the first-in-human study of GUB-UCN2, the company's lead asset for high quality weight loss, has been submitted to the Competent Autho ...

A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.

Atomic force microscopy (BioAFM) drives innovation in cosmetics and healthcare, ensuring product efficacy through precise ...

With their unique cellulose architecture, paper batteries present a promising alternative for low-cost, biodegradable energy ...

Reduced progression of myocardial fibrosis measured by LGE on cardiac MRI (p=0.022)Significant improvement in LVEF versus placebo in patients ...